ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,822.67
      -0.13%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Evogene Ltd (EVGN)

      7. Evogene Ltd (EVGN) Financials

      Evogene Ltd

      Evogene Ltd (EVGN)

      Evergen Infrastructure Corp
      5.14
      0.30
      (6.20%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      5.14
      0.00
      (0.00%)
      After Hours: 6:55PM
      Delayed by 15 minutes

      Evogene Ltd Financial Summary

      The current EVGN market cap is 260M. The company's latest EPS is USD -0.4721 and P/E is -10.80.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 312k466k641k654k3.77M
      Operating Income -8.01M-7.1M-6.8M-7.9M-4.18M
      Net Income -8.82M-6.53M-6.27M-7.02M-3.98M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 753k1.04M930k5.18M5.64M
      Operating Income -21.17M-24.81M-30.95M-26.94M-26.51M
      Net Income -18.11M-23.37M-27.79M-26.64M-23.88M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 56.66M59.39M49.48M53.34M57.75M
      Total Liabilities 11.27M21.09M20.98M22.23M21.88M
      Total Equity 45.4M38.3M28.5M31.11M35.86M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 71.36M71.92M76.3M56.13M51.1M
      Total Liabilities 11.15M15.03M12.88M21.34M22.42M
      Total Equity 60.22M56.88M63.42M34.79M28.69M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.66M-7.06M-6.24M-5.09M-4.32M
      Investing 1.76M-22k304k-7.9M3.64M
      Financing -369k10.17M53k10.45M7.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -17.67M-19.51M-24.72M-23.68M-21.58M
      Investing 37.14M9.42M-20.57M13.27M-4.54M
      Financing 9.31M20.37M30.28M9.34M18.15M

      Stats and Ratios

      Market Cap 260M
      Price to Earnings Ratio -10.80
      Price to Sales Ratio 45.74
      Price to Cash Ratio 12.42
      Price to Book Ratio 8.99
      Dividend Yield -

      Share Statistics

      Shares Outstanding 50.58M
      Average Volume (1 week) 370.01k
      Average Volume (1 Month) 188.93k
      52 Week Change -51.05%
      52 Week High 11.00
      52 Week Low 4.502
      Spread (Intraday) 0.27 (5.18%)

      Company Info

      Company Name Evogene Ltd
      Address 13 gad feinstein street, park rehovot
      rehovot, center 7414002
      Website https://www.evogene.com
      Industry biological pds,ex diagnstics (2836)